Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report

Documenti analoghi

• A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition
  di: Zhang, Nana, et al.
  Pubblicazione: (2017)
• Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?
  di: Hirsch, Fred R.
  Pubblicazione: (2014)
• Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
  di: Del Re, Marzia, et al.
  Pubblicazione: (2016)
• Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs
  di: Lin, Jessica J., et al.
  Pubblicazione: (2015)
• Overcoming T790M mutant small cell lung cancer with the third‐generation EGFR‐TKI osimertinib
  di: Kejing Tang, et al.
  Pubblicazione: (2019-02-01)